Pilot study to embed electronic Patient Reported Outcome Measures and patient reported experience measures into routine care for patients with Stage III MELanoma (ePROMs-MEL)

Not Applicable

• Conditions: Melanoma - Stage III; Psychosocial stress; Quality of life; Mental Health; Cancer - Malignant melanoma

• Registration Number: ACTRN12620001149954
• Lead Sponsor: The University of Sydney

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2020-11-03
• Last Update Posted: 9 November 2020

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

Patient key inclusion criteria:
•Adults (over 18)
•Diagnosis of Stage III melanoma at least 3 months earlier
•Under the care of melanoma clinicians at MIA or RPAH
•Sufficient English and cognitive ability to comprehend study materials, provide informed consent and participate in this study
Clinician inclusion criteria:
•Clinicians currently treating and managing patients with stage III melanoma at Sydney Melanoma Surgical Oncology clinics at MIA or RPAH.

Exclusion Criteria

None

Study & Design

• Study Type: Interventional
• Study Design: Not specified